Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation

Fig. 3

Shows Cost-effectiveness Acceptability Curves (CEACs) for the probability that LAA occlusion strategy was the most cost-effective compared with other 7 strategies for a range of willingness to pay threshold. Given a maximum acceptable ceiling ratio of US$50,000 per QALY gained, the probability of cost-effectiveness for LAA occlusion strategy was 86.24 %

Back to article page